Botswana vs Lithuania: Reported cases of paralytic polio

Botswana
0 cases
in 2023
Lithuania
0 cases
in 2023
Botswana rank
26th
Lithuania rank
26th

Reported cases of paralytic polio over time

  • Botswana
  • Lithuania
012345198020012023

How they compare

Botswana currently reports 0 cases against 0 cases in Lithuania, a difference of 0 cases.

The two have swapped places 4 times across 33 shared years of data; in 1991 it was Lithuania ahead.

Botswana ranks 26th and Lithuania ranks 26th of 199 countries.

Botswana has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Botswana Lithuania Difference Ahead
1990s 0.3333 cases 0 cases 0.3333 cases Botswana
2000s 0.1 cases 0 cases 0.1 cases Botswana
2010s 0 cases 0 cases 0 cases
2020s 0 cases 0 cases 0 cases

Averages of every year both report within each decade.

Frequently asked questions

Which has higher reported cases of paralytic polio, Botswana or Lithuania?
Botswana, at 0 cases against 0 cases in Lithuania as of 2023.
What is the difference in reported cases of paralytic polio between Botswana and Lithuania?
0 cases, with Botswana ahead.
How many years of comparable data are there for Botswana and Lithuania?
33 years are reported by both, from 1991 to 2023.
How do Botswana and Lithuania rank globally for reported cases of paralytic polio?
Botswana ranks 26th and Lithuania ranks 26th of 199 countries.
Where does this data come from?
World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Reported cases of paralytic polio
Unit
cases
Source
World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
199 places, 7,608 data points, 1980–2023
Last refreshed

The sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.